logo image
search icon
Advanced Drug Delivery CDMO Market

Advanced Drug Delivery CDMO Market Size, Share & Trends Analysis Report By Services (Development and Manufacturing Services, Analytical Services, Assembly, Labelling and Packaging, Others), By Region, And By Segment Forecasts, 2023-2031.

Report ID : 2138 | Published : 2023-11-23 | Pages: 179 | Format: PDF/EXCEL

Advanced Drug Delivery CDMO Market Size is predicted to show a 4.91% CAGR during the forecast period for 2023-2031.

Advanced Drug Delivery CDMO Market

The pharmaceutical sector greatly benefits from a Contract Development and Manufacturing Organisation (CDMO) specialising in cutting-edge drug delivery technologies. These CDMOs offer services for creating, formulating, and developing drug delivery systems beyond conventional oral tablets or capsules. Modern medication delivery systems have arisen as a quick and precise way to get the drug to the right place. These systems have many advantages over conventional systems, including the focused and regulated delivery of novel molecules to target areas, the consistency of drug absorption, the elimination of frequent dosing, the decrease of hazardous metabolites, and reduced variability in systemic drug concentrations. The need for advanced drug delivery CDMOs has increased as a result of improved drug performance and superior results brought about by advanced drug delivery systems.

However, the Advanced Drug Delivery Contract Development and Manufacturing Organisation (CDMO) market was significantly impacted by the COVID-19 pandemic, which had a wide-ranging effect on the sector. The pandemic affected the availability of raw materials and parts needed for medicine delivery systems by upsetting global supply chains. For several CDMOs, this resulted in manufacturing difficulties and delivery delays.

Competitive Landscape

Some Major Key Players In The Advanced Drug Delivery CDMO Market:

  • Evonik Health Care
  • SHL Medical
  • Lubrizol Life Science
  • Acino International AG
  • Pharmathen
  • Phillips-Medisize (A Molex Company)
  • Others

Market Segmentation:

The Advanced Drug Delivery CDMO Market is segmented on the basis of services which is segmented as Analytical Services, Assembly, Labelling and Packaging, and Others.

The Segment, Analytical Services, Accounted As A Major Contributor In The Advanced Drug Delivery CDMO Market. 

The analytical services category is expected to hold a major share in the global Advanced Drug Delivery CDMO Market in 2022. The Advanced Drug Delivery Contract Development and Manufacturing Organisation (CDMO) industry heavily relies on analytical services. These services cover a range of analytical and testing procedures used to assess the effectiveness, reliability, and performance of drug delivery systems. Nanoparticles, liposomes, and biodegradable microspheres are just a few of the complex formulations that are frequently used in the creation of sophisticated drug delivery systems. In order to characterize and validate these complex compositions, analytical services are crucial.

In The Region, The North American Advanced Drug Delivery CDMO Market Holds A Significant Revenue Share.

The North America Advanced Drug Delivery CDMO Market is expected to record the maximum market share in terms of revenue in the near future. The region's long-standing CDMO presence distinguishes the market in North America. The region is heavily invested in researching and developing biological medications, gene treatments, and other specialized pharmaceuticals. These complex compounds frequently necessitate specialized drug delivery devices, which drives demand for CDMO services.

Along with this element, expanding partnerships between pharmaceutical firms and CDMOs providing a wide range of services are to blame for the region's leading market share globally. Due to the region's highly qualified workforce and low manufacturing and R&D costs, the Asia Pacific market is estimated to grow significantly over the course of the forecast period.

Recent Developments:

  • In July 2023, SHL Medical said it had bought LCA Automation AG, a Swiss company that makes innovative automation solutions. The purchase was SHL Medical's answer to the growing need for drug delivery options in the market. It also helped its manufacturing operations around the world, especially the new factory that will open in Zug, Switzerland. 
  • In March 2023, Evonik has solidified its prominent position in drug delivery for RNA treatments by initiating the construction process for a new pharmaceutical lipids plant in the United States. The newly established facility was anticipated to ensure the industry's uninterrupted availability of essential excipients required for mRNA vaccines and other nucleic acid therapeutics. The commencement of plant operations was planned for the year 2025.

Advanced Drug Delivery CDMO Market Report Scope

Report Attribute

Specifications

Growth Rate CAGR

CAGR of 4.91% from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Services

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Evonik Health Care, SHL Medical, Lubrizol Life Science, Acino International AG, Pharmathen, Phillips-Medisize (A Molex Company), and others.

Customization Scope

Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Advanced Drug Delivery CDMO Market Snapshot

Chapter 4. Global Advanced Drug Delivery CDMO Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. COVID-19 Impact Analysis

Chapter 5. Market Segmentation 1: By Service Estimates & Trend Analysis

5.1. By Service & Market Share, 2019-2031

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Service:

5.2.1. Development and Manufacturing Services

5.2.2. Analytical Services

5.2.3. Assembly, Labelling and Packaging

5.2.4. Other Services

Chapter 6. Advanced Drug Delivery CDMO Market Segmentation 2: Regional Estimates & Trend Analysis

6.1. North America

6.1.1. North America Advanced Drug Delivery CDMO Market revenue (US$ Million) estimates and forecasts By Service, 2023-2031

6.1.2. North America Advanced Drug Delivery CDMO Market revenue (US$ Million) estimates and forecasts by country, 2023-2031

6.1.2.1. U.S.

6.1.2.2. Canada

6.2. Europe

6.2.1. Europe Advanced Drug Delivery CDMO Market revenue (US$ Million) By Service, 2023-2031

6.2.2. Europe Advanced Drug Delivery CDMO Market revenue (US$ Million) By country, 2023-2031

6.2.2.1. Germany

6.2.2.2. Poland

6.2.2.3. France

6.2.2.4. Italy

6.2.2.5. Spain

6.2.2.6. UK

6.2.2.7. Rest of Europe

6.3. Asia Pacific

6.3.1. Asia Pacific Advanced Drug Delivery CDMO Market revenue (US$ Million) By Service, 2023-2031

6.3.2. Asia Pacific Advanced Drug Delivery CDMO Market revenue (US$ Million) By country, 2023-2031

6.3.2.1. China

6.3.2.2. India

6.3.2.3. Japan

6.3.2.4. Australia

6.3.2.5. Rest of Asia Pacific

6.4. Latin America

6.4.1. Latin America Advanced Drug Delivery CDMO Market revenue (US$ Million) By Service, 2023-2031

6.4.2. Latin America Advanced Drug Delivery CDMO Market revenue (US$ Million) By country, (US$ Million) 2023-2031

6.4.2.1. Brazil

6.4.2.2. Rest of Latin America

6.5. Middle East & Africa

6.5.1. Middle East & Africa Advanced Drug Delivery CDMO Market revenue (US$ Million) By Service, (US$ Million)

6.5.2. Middle East & Africa Advanced Drug Delivery CDMO Market revenue (US$ Million) By country, (US$ Million) 2023-2031

6.5.2.1. South Africa

6.5.2.2. GCC Countries

6.5.2.3. Rest of MEA

Chapter 7. Competitive Landscape

7.1. Major Mergers and Acquisitions/Strategic Alliances

7.2. Company Profiles

7.2.1. Evonik Health Care

7.2.2. SHL Medical

7.2.3. Phillips-Medisize - A Molex Company

7.2.4. Lubrizol Life Science

7.2.5. Acino International AG

7.2.6. Pharmathen

7.2.7. Other Players

Segmentation of Advanced Drug Delivery CDMO Market -

By Services-

  • Analytical Services
  • Assembly
  • Labelling and Packaging
  • Others

Advanced Drug Delivery CDMO Market Seg

Advanced Drug Delivery CDMO Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Advanced Drug Delivery CDMO Market Size?

Evonik Health Care, SHL Medical, Lubrizol Life Science, Acino International AG, Pharmathen, Phillips-Medisize (A Molex Company), and others.

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach